The authors delineated the mechanistic actions of APE1/IL-6 signalling in Erlotinib resistance of non-small cell lung cancer.
[Clinical and Translational Medicine]
Home Newsletters Cancer Stem Cell News APE1 shRNA-Loaded Cancer Stem Cell-Derived Extracellular Vesicles Reverse Erlotinib Resistance in Non-Small...
